Previous Close | 0.0500 |
Open | 0.0450 |
Bid | 0.0450 x 0 |
Ask | 0.0500 x 0 |
Day's Range | 0.0450 - 0.0450 |
52 Week Range | 0.0400 - 0.1800 |
Volume | |
Avg. Volume | 251,693 |
Market Cap | 14.033M |
Beta (5Y Monthly) | 1.75 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0240 |
Earnings Date | Feb 15, 2022 - Feb 21, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | Jan 27, 2017 |
1y Target Est | 0.12 |
DUBLIN, Ireland, May 02, 2022 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that it will host a conference call and live webcast at 8:30 a.m. ET on Monday, May 9, 2022, to provide a corporate update and discuss the Company's financial results for the first quarter ended March 31, 2022. To access the conference call, investors are invited to dial (844) 388-0559 (U.S. and Canada) or (
Martello Technologies Group Inc., ("Martello" or the "Company") (TSXV: MTLO), a leading developer of enterprise digital experience monitoring ("DEM") solutions that optimize the modern workplace, announced today the appointment of Jim Clark as Chief Financial Officer ("CFO"), effective May 2, 2022.
Martello Technologies Group Inc., ("Martello" or the "Company") (TSXV: MTLO), a leading developer of enterprise digital experience monitoring ("DEM") solutions, today announced a partnership with Orange Business Services ("Orange"), the business services arm of Orange SA, a global network-native digital services company. Martello's Vantage DX SaaS platform will be integrated in the Orange Business Together with Microsoft portfolio. As a global provider of end-to-end and fully managed collaborati